Windlas Biotech Limited (WINDLAS.BO)
INR 924.95
(-0.21%)
INR 924.95
(-0.21%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 581.87 Million INR | 36.51% |
| 2022 | 426.26 Million INR | 11.91% |
| 2021 | 380.89 Million INR | 140.58% |
| 2020 | 158.32 Million INR | -2.35% |
| 2019 | 162.13 Million INR | -74.6% |
| 2018 | 638.22 Million INR | 469.94% |
| 2017 | 111.98 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 134.79 Million INR | -20.68% |
| 2023 Q2 | 140.31 Million INR | 16.3% |
| 2023 Q3 | 150.98 Million INR | 7.6% |
| 2023 FY | 581.87 Million INR | 36.51% |
| 2023 Q1 | 120.65 Million INR | 5.43% |
| 2023 Q4 | 169.93 Million INR | 12.55% |
| 2022 Q2 | 121.94 Million INR | 24.43% |
| 2022 FY | 426.26 Million INR | 11.91% |
| 2022 Q4 | 114.44 Million INR | 24.55% |
| 2022 Q3 | 91.88 Million INR | -24.65% |
| 2022 Q1 | 98 Million INR | -33.73% |
| 2021 Q4 | 147.88 Million INR | 77.87% |
| 2021 FY | 380.89 Million INR | 140.58% |
| 2021 Q3 | 83.14 Million INR | 0.17% |
| 2021 Q2 | 83 Million INR | 24.12% |
| 2021 Q1 | 66.87 Million INR | 13.42% |
| 2020 Q4 | 58.96 Million INR | -51.99% |
| 2020 Q3 | 122.82 Million INR | 30.13% |
| 2020 Q1 | -117.82 Million INR | -2644.71% |
| 2020 Q2 | 94.38 Million INR | 180.11% |
| 2020 FY | 158.32 Million INR | -2.35% |
| 2019 FY | 162.13 Million INR | -74.6% |
| 2019 Q4 | 4.63 Million INR | 0.0% |
| 2018 FY | 638.22 Million INR | 469.94% |
| 2017 FY | 111.98 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 90.551% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 98.166% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 87.643% |
| Granules India Limited | 4.05 Billion INR | 85.644% |
| Indoco Remedies Limited | 984.6 Million INR | 40.903% |
| Achyut Healthcare Limited | 5.73 Million INR | -10051.256% |
| Ajanta Pharma Limited | 8.16 Billion INR | 92.871% |
| Alkem Laboratories Limited | 17.95 Billion INR | 96.76% |
| Alpa Laboratories Limited | 167.76 Million INR | -246.836% |
| Brooks Laboratories Limited | -195.91 Million INR | 396.995% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 63.973% |
| Bajaj HealthCare Limited | -837.93 Million INR | 169.441% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 22.884% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 98.955% |
| Eris Lifesciences Limited | 3.91 Billion INR | 85.156% |
| FDC Limited | 3.05 Billion INR | 80.936% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 103.875% |
| Gufic Biosciences Limited | 861.35 Million INR | 32.447% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 86.178% |
| Ipca Laboratories Limited | 5.47 Billion INR | 89.369% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -159.035% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 394.94% |
| Lasa Supergenerics Limited | -217.3 Million INR | 367.765% |
| Laurus Labs Limited | 1.6 Billion INR | 63.758% |
| Lupin Limited | 19.14 Billion INR | 96.961% |
| Mankind Pharma Limited | 19.12 Billion INR | 96.958% |
| Medicamen Biotech Limited | 109.31 Million INR | -432.312% |
| Medico Remedies Limited | 82.9 Million INR | -601.818% |
| Megasoft Limited | -127.46 Million INR | 556.49% |
| NATCO Pharma Limited | 13.88 Billion INR | 95.809% |
| Piramal Pharma Limited | 178.2 Million INR | -226.526% |
| RPG Life Sciences Limited | 876.6 Million INR | 33.622% |
| Sigachi Industries Limited | 571.8 Million INR | -1.761% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.392% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 80.622% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -129.859% |
| Unichem Laboratories Limited | -704.74 Million INR | 182.565% |
| Wanbury Limited | 559.56 Million INR | -3.987% |
| ZIM Laboratories Limited | 172.46 Million INR | -237.386% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 98.492% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 115.027% |
| Divi's Laboratories Limited | 16 Billion INR | 96.363% |
| Hester Biosciences Limited | 188.89 Million INR | -208.047% |
| Procter & Gamble Health Limited | 2 Billion INR | 71.048% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -29.383% |
| Bal Pharma Limited | 73.92 Million INR | -687.14% |
| Strides Pharma Science Limited | -706.14 Million INR | 182.402% |
| Venus Remedies Limited | 284.9 Million INR | -104.231% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 73.174% |
| Nectar Lifesciences Limited | 49.95 Million INR | -1064.905% |
| Shilpa Medicare Limited | 318.74 Million INR | -82.552% |
| Aarti Drugs Limited | 1.71 Billion INR | 66.056% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 56.716% |
| Suven Life Sciences Limited | -1.05 Billion INR | 155.376% |
| Ind-Swift Limited | 142.31 Million INR | -308.866% |
| Valiant Laboratories Limited | 3.19 Million INR | -18106.195% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 89.471% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 110.255% |
| Themis Medicare Limited | 435.23 Million INR | -33.69% |
| Hikal Limited | 696.02 Million INR | 16.4% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 96.487% |
| Sequent Scientific Limited | -358.69 Million INR | 262.221% |
| Novartis India Limited | 851.9 Million INR | 31.697% |
| Wockhardt Limited | -4.63 Billion INR | 112.567% |
| Jubilant Pharmova Limited | 771 Million INR | 24.53% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -8104.597% |
| Neuland Laboratories Limited | 3 Billion INR | 80.609% |
| Morepen Laboratories Limited | 961.59 Million INR | 39.489% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -298.503% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 741.412% |